TRIM37 contributes to malignant outcomes and CDDP resistance in gastric cancer.
Nishibeppu K, Komatsu S, Kiuchi J, Kishimoto T, Takashima Y, Shoda K, Arita T, Kosuga T, Konishi H, Shiozaki A, Kubota T, Okamoto K, Fujiwara H, Tsuda H, Otsuji E.
Nishibeppu K, et al. Among authors: kishimoto t.
J Cancer. 2021 Jan 1;12(2):316-325. doi: 10.7150/jca.47577. eCollection 2021.
J Cancer. 2021.
PMID: 33391428
Free PMC article.